Literature DB >> 25862911

Assessment of circulating serum DNA integrity in colorectal cancer patients.

Ebru E Yörüker1, Emre Özgür1, Metin Keskin2, Nejat Dalay1, Stefan Holdenrieder3, Ugur Gezer4.   

Abstract

UNLABELLED: Background /Aim: Studies evaluating the integrity of cell-fee DNA (cfDNA) in colorectal cancer (CRC) have led to inconsistent results. Herein, we analyzed the utility of two different DNA integrity indexes (ACTB(384)/ACTB(106) and ALU(247)/ALU(115)) to assess cfDNA fragmentation in Turkish CRC patients. The correlation of circulating nucleosomes (cNUC) with the fragment sizes was also evaluated.
MATERIALS AND METHODS: Seventy two CRC patients and 42 CRC-free control individuals were enrolled in the study. cfDNA was analyzed by quantitative polymerase chain reaction (qPCR).
RESULTS: While with ALU(247)/ALU(115)there was a small difference between the groups, an approximately 3-fold (median values=0.12 and 0.34) lower integrity was found in the patients using the ACTB(384)/ACTB(106) ratio (p=0.06). The correlation between cNUC and qPCR threshold cycles was much higher for shorter fragments.
CONCLUSION: Lower DNA integrity and the predominance of mononuclesomes in serum reveal high fragmentation of cfDNA in CRC patients. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  DNA integrity; circulating cell-free DNA; circulating nucleosomes; colorectal cancer

Mesh:

Substances:

Year:  2015        PMID: 25862911

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

Review 1.  The Utility of Repetitive Cell-Free DNA in Cancer Liquid Biopsies.

Authors:  Ugur Gezer; Abel J Bronkhorst; Stefan Holdenrieder
Journal:  Diagnostics (Basel)       Date:  2022-06-01

2.  Fragmentation Analysis of Plasma DNA Reveals Its Prognostic Value in Gastric Cancer.

Authors:  Ebru Esin Yoruker; Emre Ozgur; Metin Keskin; Ilker Ozgur; Ugur Gezer
Journal:  Turk J Gastroenterol       Date:  2021-09       Impact factor: 1.555

3.  The Prognostic Value of Circulating Cell-Free DNA in Colorectal Cancer: A Meta-Analysis.

Authors:  Shiva Basnet; Zhen-Yu Zhang; Wen-Qiang Liao; Shu-Heng Li; Ping-Shu Li; Hai-Yan Ge
Journal:  J Cancer       Date:  2016-06-04       Impact factor: 4.207

Review 4.  Role of circulating free DNA in colorectal cancer.

Authors:  Alexios Matikas; Alexandra Voutsina; Maria Trypaki; Vassilis Georgoulias
Journal:  World J Gastrointest Oncol       Date:  2016-12-15

5.  Liquoral liquid biopsy in neoplastic meningitis enables molecular diagnosis and mutation tracking: a proof of concept.

Authors:  Caterina Marchiò; Sara Mariani; Luca Bertero; Cristiana Di Bello; Paola Francia Di Celle; Mauro Papotti; Roberta Rudà; Riccardo Soffietti; Paola Cassoni
Journal:  Neuro Oncol       Date:  2017-03-01       Impact factor: 12.300

Review 6.  Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature.

Authors:  Michail Galanopoulos; Nikolaos Tsoukalas; Ioannis S Papanikolaou; Maria Tolia; Maria Gazouli; Gerassimos J Mantzaris
Journal:  World J Gastrointest Oncol       Date:  2017-04-15

7.  Plasma cell-free DNA quantification is highly correlated to tumor burden in children with neuroblastoma.

Authors:  Xisi Wang; Lijun Wang; Yan Su; Zhixia Yue; Tianyu Xing; Wen Zhao; Qian Zhao; Chao Duan; Cheng Huang; Dawei Zhang; Mei Jin; Xianfeng Cheng; Shenglan Chen; Yi Liu; Xiaoli Ma
Journal:  Cancer Med       Date:  2018-06-14       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.